Seeking Alpha

Prudent Man CFA » Comments » ALXN

  • 5 Potential Buyout Targets in Biotech - Barron's [View article]
    The patent expiration problems of large pharma are well know. This article would have added value if the specific reasons why the target companies were potential takeovers would have given substance to it.

    In this day where primary research is virtually missing and everyone seems to be peddling their portfolio, it would be refreshing to get sound reasoning backed by substantive facts rather than mere opinions which are worth exactly what you pay for them.
    Aug 17 11:22 am |Rating: +1 0 |Link to Comment
More on ALXN by Prudent Man CFA
Comments by Ticker
AA, AAPL, AAXJ, ABI, ABT, ABX, ACH, ACI, ACS, ACTL, ACWI, ADBE, ADM, ADRE, ADSK, AFK, AGG, AHBIF.PK, AIB, AIG, AKP, ALTR, ALVR, ALXN, AMAT, AMD, AMGN, AMLN, AMZN, APA, APC, APOL, AWF, AXP, AZ, AZN, BA, BAC, BBI, BC, BCE, BCS, BFSB, BG, BGU, BGZ, BIDU, BIL, BIV, BK,
Prudent Man CFA is a
Top 100 Commentor
733 comments
Rating: 1348 (2837 - 1489 )